Literature DB >> 30063500

Metastatic Salivary Ductal Carcinoma to the Mastoid Segment of the Facial Nerve.

Joshua E Fabie1, Jonathan L Hatch1, Ashley W Cross2, Samuel L Oyer1, David M Neskey1, Theodore R McRackan1.   

Abstract

OBJECTIVE: To describe salivary ductal carcinoma (SDC) presenting as an isolated lesion of the mastoid segment of the facial nerve PATIENTS:: A 70-year-old man presenting with weakness of his right lower lip that progressed to complete facial paralysis over a span of 2 weeks. MAIN OUTCOME MEASURES: Clinical case records, immunohistochemical analyses, and radiological analyses including magnetic resonance imaging and positron emission tomography-computed tomography.
RESULTS: Nodular enhancement along the mastoid segment of the facial nerve was identified without any mass within the parotid on magnetic resonance imaging or regional/distant disease on positron emission tomography-computed tomography. Pathologic analysis of tissue obtained from a right parotidectomy, neck dissection, and transmastoid resection of the vertical segment of the facial nerve revealed a benign parotid gland with malignant glands identified intra- and perineurally within the central aspect of the gland.
CONCLUSIONS: SDC is one of the most aggressive salivary malignancies and typically presents as a rapidly enlarging mass in the involved gland. Although SDC's clinical course is characterized by early metastasis, isolated neural invasion has not been reported in the absence of an identifiable primary tumor within the gland of origin. The present case illustrates the clinical history and treatment of the first case of a SDC presenting as an isolated facial nerve lesion from perineural spread.

Entities:  

Mesh:

Year:  2018        PMID: 30063500      PMCID: PMC6095726          DOI: 10.1097/MAO.0000000000001923

Source DB:  PubMed          Journal:  Otol Neurotol        ISSN: 1531-7129            Impact factor:   2.311


  12 in total

1.  World Health Organization classification of tumours: pathology and genetics of head and neck tumours.

Authors:  Lester Thompson
Journal:  Ear Nose Throat J       Date:  2006-02       Impact factor: 1.697

2.  Molecular characterization of apocrine salivary duct carcinoma.

Authors:  Simion I Chiosea; Lindsay Williams; Christopher C Griffith; Lester D R Thompson; Ilan Weinreb; Julie E Bauman; Alyssa Luvison; Somak Roy; Raja R Seethala; Marina N Nikiforova
Journal:  Am J Surg Pathol       Date:  2015-06       Impact factor: 6.394

3.  Clinical and immunohistologic typing of salivary duct carcinoma: a report of 50 cases.

Authors:  Michael Jaehne; Kerstin Roeser; Thorsten Jaekel; Jan David Schepers; Natalie Albert; Thomas Löning
Journal:  Cancer       Date:  2005-06-15       Impact factor: 6.860

Review 4.  Salivary duct carcinoma: what is already known, and can we improve survival?

Authors:  D T H Wee; A A Thomas; P J Bradley
Journal:  J Laryngol Otol       Date:  2012-04-12       Impact factor: 1.469

Review 5.  Recent advances in the diagnostic pathology of salivary carcinomas.

Authors:  Roderick H W Simpson; Alena Skálová; Silvana Di Palma; Ilmo Leivo
Journal:  Virchows Arch       Date:  2014-08-30       Impact factor: 4.064

6.  Facial paralysis caused by malignant skull base neoplasms.

Authors:  Sam J Marzo; John P Leonetti; Guy Petruzzelli
Journal:  Ear Nose Throat J       Date:  2002-12       Impact factor: 1.697

7.  An immunohistochemical panel for reliable differentiation of salivary duct carcinoma and mucoepidermoid carcinoma.

Authors:  Randall T Butler; Matthew E Spector; Dafydd Thomas; Andrew S McDaniel; Jonathan B McHugh
Journal:  Head Neck Pathol       Date:  2013-09-25

Review 8.  Salivary duct carcinoma. Part I. A clinicopathologic evaluation and DNA image analysis of 13 cases with review of the literature.

Authors:  L Barnes; U Rao; J Krause; L Contis; A Schwartz; P Scalamogna
Journal:  Oral Surg Oral Med Oral Pathol       Date:  1994-07

9.  Detection of novel actionable genetic changes in salivary duct carcinoma helps direct patient treatment.

Authors:  Valentina Nardi; Peter M Sadow; Dejan Juric; Dave Zhao; Arjola K Cosper; Kristin Bergethon; Vanessa L Scialabba; Julie M Batten; Darrell R Borger; Anthony John Iafrate; Rebecca S Heist; Donald P Lawrence; Keith T Flaherty; Johanna C Bendell; Daniel Deschler; Yi Li; Lori J Wirth; Dora Dias-Santagata
Journal:  Clin Cancer Res       Date:  2012-11-27       Impact factor: 12.531

10.  Salivary duct carcinoma.

Authors:  A Sefik Hosal; Chunyang Fan; Leon Barnes; Eugene N Myers
Journal:  Otolaryngol Head Neck Surg       Date:  2003-12       Impact factor: 5.591

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.